Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Drug Elimination: The Concept of Clearance

Drug Elimination: The Concept of Clearance

Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantitative ballistocardiography (Q-BCG) for measurement of cardiovascular dynamics.

Physiological research·2011

Same author

The new clearance method for hepatic diagnostics.

Prague medical report·2006

Same author

Electrocardiographic body surface maps (BSM) in patients with ischemic heart disease examined by coronary angiography.

Prague medical report·2005

Same author

[Effect of a 10-day animal fat-free diet on cholesterol and glucose serum levels, blood pressure and body weight in 50-year-old volunteers].

Sbornik lekarsky·2002

Same author

[Thoracic electric bioimpedance].

Casopis lekaru ceskych·1995

Same author

[A system for monitoring hemodynamic data and treatment of arterial hypertension (Part I. Evaluation of long-term results of classical therapy)].

Vnitrni lekarstvi·1994

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

New clearance evaluation method for hepatological diagnostics.

J A Tichý¹, M Loucka, Z M Trefný

¹Institute of Chemical Technology, Department of Mathematics, Prague, Czech Republic.

Physiological Research

|October 24, 2007

Summary

Pulse dye densitometry (PDD) offers a safe, non-invasive method to assess liver function and hemodynamics. This technique reliably tracks liver disease progression and aids in hepatopathy staging using parameters like C5-clearance and T-index.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Published on: December 13, 2024

Related Experiment Videos

Last Updated: Jul 10, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Published on: December 13, 2024

Area of Science:

Hepatology
Medical Diagnostics
Hemodynamics

Background:

Pulse dye densitometry (PDD) is a valuable tool for assessing liver function and hemodynamic status.
Repeated PDD examinations can safely monitor liver pathology dynamics, even under stress or after short pauses.

Purpose of the Study:

To evaluate the reliability of PDD-derived parameters for liver function assessment.
To explore the correlation of PDD parameters with hepatopathy staging and functional grading.
To highlight the utility of an automated Japanese analyzer for indocyanine green (ICG) analysis in complex hepatological diagnostics.

Main Methods:

Utilized pulse dye densitometry (PDD) for hemodynamic and liver function evaluation.
Analyzed C5-clearance as an indicator of liver system equilibrium.
Calculated the T-index (C5 value to cardiac output ratio) as a sensitive indicator of sinusoidal uptake.
Incorporated a two-compartment mathematical model with an automated Japanese analyzer for indocyanine green (ICG) dilution and elimination curves.

Main Results:

C5-clearance was identified as a reliable parameter for assessing the equilibrium state of the two-compartment liver system.
The T-index demonstrated a strong correlation with the staging of hepatopathies, indicating sinusoidal uptake efficiency.
The isolated h constant, in correlation with the T-index, proved valuable for functional grading of the liver.

Conclusions:

Non-invasive PDD provides clinically significant results comparable to invasive methods.
PDD allows for repeated examinations at short intervals with minimal patient stress, enhancing its clinical importance.
The integration of a two-compartment model with automated ICG analysis significantly increases the diagnostic utility of PDD in hepatology.